MATCHX Trademark
Trademark Overview
On Monday, April 22, 2024, a trademark application was filed for MATCHX with the United States Patent and Trademark Office. The USPTO has given the MATCHX trademark a serial number of 98513198. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Monday, June 30, 2025. This trademark is owned by Immucor, Inc.. The MATCHX trademark is filed in the Computer & Software Products & Electrical & Scientific Products and Computer & Software Services & Scientific Services categories with the following description:
Downloadable and recorded computer software for performing and reporting antibody analysis; Downloadable and recorded computer software for use in evaluating human leukocyte antigen (HLA) test results and for performing antibody screening and antibody crossmatch testing; downloadable and recorded computer software for processing, interpreting and analyzing in-vitro diagnostic tests, namely, for testing and reporting on biological samples in transplantation and disease association; Downloadable and recorded computer software for processing, interpreting and analyzing in-vitro diagnostic tests, namely, for managing and analyzing transplant test results; Downloadable and recorded computer software for processing, interpreting and analyzing in-vitro diagnostic tests, namely, for donor-recipient antibody and eplet mapping to evaluate transplant compatibility; Downloadable and recorded computer software for processing, interpreting and analyzing in-vitro diagnostic tests, namely, for detecti...
Providing online, non-downloadable computer software for performing and reporting antibody analysis; Providing online, non-downloadable computer software for use in evaluating human leukocyte antigen (HLA) test results and for performing antibody screening and antibody crossmatch testing; Providing online, non-downloadable computer software for processing, interpreting and analyzing in-vitro diagnostic tests, namely, for testing and reporting on biological samples in transplantation and disease association; Providing online, non-downloadable computer software for processing, interpreting and analyzing in-vitro diagnostic tests, namely, for managing and analyzing transplant test results; Providing online, non-downloadable computer software for processing, interpreting and analyzing in-vitro diagnostic tests, namely, for donor-recipient antibody and eplet mapping to evaluate transplant compatibility; Providing online, non-downloadable computer software for processing, interpreting and an...
General Information
| Serial Number | 98513198 |
| Word Mark | MATCHX |
| Filing Date | Monday, April 22, 2024 |
| Status | 645 - FINAL REFUSAL - MAILED |
| Status Date | Monday, June 30, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Downloadable and recorded computer software for performing and reporting antibody analysis; Downloadable and recorded computer software for use in evaluating human leukocyte antigen (HLA) test results and for performing antibody screening and antibody crossmatch testing; downloadable and recorded computer software for processing, interpreting and analyzing in-vitro diagnostic tests, namely, for testing and reporting on biological samples in transplantation and disease association; Downloadable and recorded computer software for processing, interpreting and analyzing in-vitro diagnostic tests, namely, for managing and analyzing transplant test results; Downloadable and recorded computer software for processing, interpreting and analyzing in-vitro diagnostic tests, namely, for donor-recipient antibody and eplet mapping to evaluate transplant compatibility; Downloadable and recorded computer software for processing, interpreting and analyzing in-vitro diagnostic tests, namely, for detecting donor genetic material for post-transplant monitoring and diagnosis and for evaluating results of in vitro diagnostic tests |
| Pseudo Mark | MATCH X |
| Goods and Services | Providing online, non-downloadable computer software for performing and reporting antibody analysis; Providing online, non-downloadable computer software for use in evaluating human leukocyte antigen (HLA) test results and for performing antibody screening and antibody crossmatch testing; Providing online, non-downloadable computer software for processing, interpreting and analyzing in-vitro diagnostic tests, namely, for testing and reporting on biological samples in transplantation and disease association; Providing online, non-downloadable computer software for processing, interpreting and analyzing in-vitro diagnostic tests, namely, for managing and analyzing transplant test results; Providing online, non-downloadable computer software for processing, interpreting and analyzing in-vitro diagnostic tests, namely, for donor-recipient antibody and eplet mapping to evaluate transplant compatibility; Providing online, non-downloadable computer software for processing, interpreting and analyzing in-vitro diagnostic tests, namely, for detecting donor genetic material for post-transplant monitoring and diagnosis and for evaluating results of in vitro diagnostic tests |
Classification Information
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, April 22, 2024 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, April 22, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | IMMUCOR GTI DIAGNOSTICS, INC. |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 03 - Corporation |
| Address | NORCROSS, GA 30071 |
| Party Name | Immucor, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Norcross, GA 30071 |
Trademark Events
| Event Date | Event Description |
| Monday, April 22, 2024 | NEW APPLICATION ENTERED |
| Monday, April 22, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, November 5, 2024 | ASSIGNED TO EXAMINER |
| Thursday, November 7, 2024 | NON-FINAL ACTION E-MAILED |
| Thursday, November 7, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Saturday, January 25, 2025 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Saturday, January 25, 2025 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, February 7, 2025 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Friday, February 7, 2025 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Tuesday, May 6, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, November 7, 2024 | NON-FINAL ACTION WRITTEN |
| Saturday, January 25, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, May 6, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, May 6, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, June 4, 2025 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Monday, June 30, 2025 | FINAL REFUSAL WRITTEN |
| Monday, June 30, 2025 | FINAL REFUSAL E-MAILED |
| Monday, June 30, 2025 | NOTIFICATION OF FINAL REFUSAL EMAILED |
